RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Cedar Park, TX · Dallas, TX · Fort Worth, TX · +37 more sites
4 recruiting ulcerative colitis studies with a site in Cedar Park, TX.
All trials in Cedar Park, TX · All Ulcerative Colitis trials
Sponsor: Eli Lilly and Company
Cedar Park, TX · Dallas, TX · Fort Worth, TX · +37 more sites
Sponsor: Spyre Therapeutics, Inc.
Cedar Park, TX · Garland, TX · San Antonio, TX · +23 more sites
Sponsor: Xencor, Inc.
Cedar Park, TX · Denton, TX · Garland, TX · +27 more sites
Sponsor: Boehringer Ingelheim
Cedar Park, TX · Houston, TX · +12 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.